Development of methods for docking and designing small molecules within the Rosetta code framework
Structure-based drug design is a key challenge for pharmaceutical chemists. By studying the structure of proteins bound to natural substrates, researchers can design small molecules which they predict will bind in a similar fashion. Ligand docking software such as RosettaLigand plays a key role in s...
Main Author: | |
---|---|
Other Authors: | |
Format: | Others |
Language: | en |
Published: |
VANDERBILT
2012
|
Subjects: | |
Online Access: | http://etd.library.vanderbilt.edu/available/etd-10152012-130148/ |